“Protenuria in SLE: Is it always lupus?”

Proteinuria is one of the most typical manifestations of kidney involvement in Systemic Lupus Erythematosus (SLE). We report the case of a 23-year-old woman with a 6-year-long history of SLE presenting with proteinuria after a three-year remission on hydroxychloroquine. Kidney histological examination showed alterations inconsistent with lupus nephritis and suggestive of hydroxychloroquine toxicity or Fabry disease. The latter was confirmed by genetic assay.

[1]  E. Frangou,et al.  2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis , 2020, Annals of the Rheumatic Diseases.

[2]  Xiang Liang,et al.  Hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease in undifferentiated connective tissue disease: A case report , 2019, World journal of clinical cases.

[3]  J. R. Machado,et al.  Ultrastructural deposits appearing as “zebra bodies” in renal biopsy: Fabry disease?– comparative case reports , 2017, BMC Nephrology.

[4]  F. Roubille,et al.  Heart Involvement in a Woman Treated with Hydroxychloroquine for Systemic Lupus Erythematosus Revealing Fabry Disease , 2016, The Journal of Rheumatology.

[5]  S. Cigarrán,et al.  Curvilinear bodies in hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease , 2013, Clinical kidney journal.

[6]  D. Isenberg,et al.  Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry’s disease , 2013, Lupus.

[7]  D. U. Kim,et al.  Clinical Mimicry: Fabry Disease Masquerading as Lupus? , 2010 .

[8]  J. Miyazaki,et al.  Novel mutations of the GLA gene in Japanese patients with Fabry disease and their functional characterization by active site specific chaperone , 2008, Human mutation.

[9]  P. Rozenfeld,et al.  High incidence of autoantibodies in Fabry disease patients , 2007, Journal of Inherited Metabolic Disease.

[10]  D. Gladman,et al.  Coexistence of Fabry's disease and systemic lupus erythematosus. , 1998, Clinical and experimental rheumatology.

[11]  N. Latov,et al.  Specificity and cross-reactivity of anti-galactocerebroside antibodies. , 1995, Immunological investigations.

[12]  O. Benveniste,et al.  Innate and Adaptive Immune Response in Fabry Disease. , 2015, JIMD reports.

[13]  C. Pérez de Ayala,et al.  [Fabry's disease associated with rheumatoid arthritis. Multisystemic crossroads]. , 2003, Anales de medicina interna.